Protara Therapeutics Inc (TARA) — Long-term Investment Intensity
Protara Therapeutics Inc (TARA) has a Long-term Investment Intensity of 20.2% as of December 2025. Long-term investments of $42.34 Million represent 20.2% of total assets of $209.47 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Protara Therapeutics Inc net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Protara Therapeutics Inc Long-term Investment Intensity (2020–2025)
This chart shows how Protara Therapeutics Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2020 to 2025. As of December 2025, the intensity stands at 20.2%, reflecting long-term investments of $42.34 Million against total assets of $209.47 Million USD. Also explore TARA asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Protara Therapeutics Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for Protara Therapeutics Inc from 2020 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Protara Therapeutics Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 20.2% | $42.34 Million | $209.47 Million | ▲ +4.4 pp |
| 2022 | 15.8% | $17.89 Million | $113.29 Million | ▼ -7.1 pp |
| 2021 | 22.9% | $39.47 Million | $172.60 Million | ▲ +22.5 pp |
| 2020 | 0.4% | $745.00K | $203.16 Million | — |